James J Litalien - Net Worth and Insider Trading
James J Litalien Net Worth
The estimated net worth of James J Litalien is at least $827,754 dollars as of 2024-11-13. James J Litalien is the SrVP/Chief Reg&Quality Officer of AveXis Inc and owns about 3,800 shares of AveXis Inc (AVXS) stock worth over $827,754. James J Litalien is also the Sr. V-P, Reg Affairs & Comp. of Ligand Pharmaceuticals Inc and owns about 0 shares of Ligand Pharmaceuticals Inc (LGND) stock worth over $0. Details can be seen in James J Litalien's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that James J Litalien has not made any transactions after 2018-04-02 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of James J Litalien
James J Litalien Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, James J Litalien owns 2 companies in total, including AveXis Inc (AVXS) , and Ligand Pharmaceuticals Inc (LGND) .
Click here to see the complete history of James J Litalien’s form 4 insider trades.
Insider Ownership Summary of James J Litalien
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| AVXS | AveXis Inc | 2018-05-15 | SrVP/Chief Reg&Quality Officer |
| LGND | Ligand Pharmaceuticals Inc | 2006-03-10 | Sr. V-P & Reg Affairs & Comp. |
James J Litalien Latest Holdings Summary
James J Litalien currently owns a total of 2 stocks. Among these stocks, James J Litalien owns 3,800 shares of AveXis Inc (AVXS) as of April 2, 2018, with a value of $827,754 and a weighting of 100%. James J Litalien also owns 0 shares of Ligand Pharmaceuticals Inc (LGND) as of June 2, 2004, with a value of $0 and a weighting of 0%.
Latest Holdings of James J Litalien
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| AVXS | AveXis Inc | 2018-04-02 | 3,800 | 217.83 | 827,754 |
| LGND | Ligand Pharmaceuticals Inc | 2004-06-02 | 0 | 120.74 | 0 |
Holding Weightings of James J Litalien
James J Litalien Form 4 Trading Tracker
According to the SEC Form 4 filings, James J Litalien has made a total of 0 transactions in AveXis Inc (AVXS) over the past 5 years. The most-recent trade in AveXis Inc is the sale of 5,000 shares on April 2, 2018, which brought James J Litalien around $597,200.
According to the SEC Form 4 filings, James J Litalien has made a total of 0 transactions in Ligand Pharmaceuticals Inc (LGND) over the past 5 years. The most-recent trade in Ligand Pharmaceuticals Inc is the sale of 102 shares on June 2, 2004, which brought James J Litalien around $12,733.
Insider Trading History of James J Litalien
- 1
James J Litalien Trading Performance
James J Litalien Ownership Network
Ownership Network List of James J Litalien
Ownership Network Relation of James J Litalien
James J Litalien Owned Company Details
What does AveXis Inc do?
Who are the key executives at AveXis Inc?
James J Litalien is the SrVP/Chief Reg&Quality Officer of AveXis Inc. Other key executives at AveXis Inc include director & President & CEO Sean P. Nolan , 10 percent owner Ag Novartis , and Chief Financial Officer Phillip B. Donenberg .
AveXis Inc (AVXS) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of AveXis Inc (AVXS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of AveXis Inc (AVXS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
AveXis Inc (AVXS)'s detailed insider trading history can be found in Insider Trading Tracker table.
AveXis Inc Insider Transactions
James J Litalien Mailing Address
Above is the net worth, insider trading, and ownership report for James J Litalien. You might contact James J Litalien via mailing address: C/o Somaxon Pharmaceuticals, Inc., 3721 Valley Centre Drive, Suite 500, San Diego Ca 92130.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
